Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The study objective is to quantify the effectiveness of ivermectin (subcutaneous/oral IVM) in the presence or absence of zinc (Zn) for clinical and radiological improvement in coronavirus disease 2019 (COVID-19) patients with moderate severity. Trial design This quadruple-blinded...

詳細記述

書誌詳細

主要な著者:	Shoaib Ashraf, Sohaib Ashraf, Iqra Farooq, Sidra Ashraf, Moneeb Ashraf, Muhammad Ahmad Imran, Larab Kalsoom, Rutaba Akmal, Muhammad Ghufran, Sundas Rafique, Muhammad Kiwan Akram, Zaigham Habib, Uzma Nasim Siddiqui, Ammara Ahmad, Shahroze Arshad, Muhammad Abdul Rehman Virk, Mehak Gul, Abeer bin Awais, Muhammad Hassan, Syed Sami Hussain Sherazi, Zartasha Safdar, Isra Munir, Hamna Khalid, Khalid Munir, Nighat Majeed, Yaser Masuod Alahmadi, Ayesha Humayun, Qazi Abdul Saboor, Ali Ahmad, Muhammad Ashraf, Mateen Izhar, DOCTORS LOUNGE Consortium
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2021-09-01
シリーズ:	Trials
主題:	Ivermectin Zinc Subcutaneous Ivermectin Pakistan COVID-19 Randomised controlled trial
オンライン･アクセス:	https://doi.org/10.1186/s13063-021-05487-z
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!